Clinical Trial Update: Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

View source ↗

Summary

A clinical trial evaluating a multiplex mutation detection method using mass spectrometry for bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Zhilong Dong | Conditions: Bladder Cancer, Bladder Cancer Recurrence | Status: RECRUITING